GENETIC · Unmapped registry intervention
BRCA1 and BRCA2
Find medicine records ·
Find other trials using this name
Clinical trial
Increase Surveillance for Breast and Ovarian Cancers, Also to Determine Targeted Risk-reducing and Preventative Strategies
NCT03319290
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedIncrease Surveillance for Breast and Ovarian Cancers, Also to Determine Targeted Risk-reducing and Preventative Strategies
Design: OBSERVATIONAL · Status: UNKNOWN · Phase: Not specified
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Hereditary Cancerunresolved
Interventions
BRCA1 and BRCA2GENETIC
Sponsors & collaborators
Data Collection Analysis Business Managementlead sponsor
PAS Research Servicescollaborator
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03319290 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.